Status:
RECRUITING
Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy
Lead Sponsor:
Covenant Health, US
Conditions:
Alzheimer Dementia
Alzheimer Disease
Eligibility:
All Genders
60-90 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to determine if utilizing the Quest AD-Detect blood test, while patient's are hospitalized for a cognitive diagnosis (such as delirium or encephalopathy), will resul...
Eligibility Criteria
Inclusion
- Ages 60 to 90 years old
- No prior diagnosis of dementia
- Currently hospitalized with cognitive diagnosis, including but no limited to; delirium, encephalopathy, etc. thought to be secondary to a toxic/metabolic state
Exclusion
- Age under 60 years
- Prior diagnosis of dementing illness or other organic etiology to cognitive impairment
Key Trial Info
Start Date :
June 10 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07222280
Start Date
June 10 2025
End Date
March 31 2026
Last Update
October 29 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Cumberland Medical Center
Crossville, Tennessee, United States, 38555
2
Roane Medical Center
Harriman, Tennessee, United States, 37748
3
Fort Sanders Regional Medical Center
Knoxville, Tennessee, United States, 37916
4
Fort Loudon Medical Center
Lenoir City, Tennessee, United States, 37772